BTG1P1

Across TCGA pan-cancer cohorts, BTG1P1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated BTG1P1 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher BTG1P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated BTG1P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and PAAD show a favorable association.

HNSC, PAAD, and BRCA are the cancer types where BTG1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	III,IV	0.687	0.501	<.001	123	view →
PAAD	DFS	Tertile	II,III,IV	0.393	0.254	.002	55	view →
BRCA	DFS	Tertile	IV	0.883	0.348	.001	46	view →
SKCM	OS	Median	All	0.900	0.841	.002	38	view →
KICH	DFS	Median	All	0.967	0.731	.010	30	view →
LUAD	DFS	Median	III,IV	0.369	0.678	.007	27	view →
KIRP	DFS	Median	III,IV	0.110	0.593	.008	26	view →
UCS	DFS	Tertile	II,III,IV	0.574	0.251	.024	24	view →
LUSC	DFS	Median	IV	0.134	0.827	.024	15	view →
ACC	OS	Tertile	IV	0.333	0.947	.024	12	view →
LAML	DFS	Median	All	0.489	0.650	.024	12	view →
CHOL	DFS	Tertile	All	0.861	0.224	.009	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

BTG1P1–HNSC (DFS)

Open the HNSC breakdown →